DGAP-Adhoc: Geratherm Medical AG: Medical heating blankets for clinical surgery

Publication of an insider information pursuant to article 17 of MAR
transmitted by DGAP - a service of EQS Group AG

Medical heating blankets for clinical surgery

Geratal, January 14, 2022. Today, Geratherm Medical AG (ISIN: DE0005495626) decided, in agreement between the Supervisory Board and Management Board, to discontinue the area of medical heating blankets for clinical surgery and the associated research and development with immediate effect. The current market situation and market prospects for the product do not reflect the associated expenses for certification according to MDR.

As of December 31, 2021, there will be a special depreciation of around EUR 900 thousand, which will be offset by annual savings, especially for R&D expenses and certifications, of around EUR 400 thousand. There are no notable declines in sales in this area due to recertification.

With this measure, the company sees itself in a stronger position for the future.

Geratherm Medical AG
Firmensitz: Fahrenheitstraße 1, 99331 Geratal
Registergericht: Amtsgericht Jena, HRB 111272
Vorstand: Christian Frick
Aufsichtsratsvorsitzender: Dr. Gert Frank
Tel. 036205/98 0; Fax: 036205/98 115
E-Mail: [email protected]
www.geratherm.com

Short company profil:
Geratherm Medical is an internationally operating medical products enterprise with the business areas Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Our company's roots are in temperature measurement in the medical sphere. In this business area we offer a broad spectrum of products, most of which have unique selling points. We supply our customers/patients with high-quality products ranging from thermometers to complex warming systems for use in the operating theatre and by emergency rescue services and MR Diagnostic Incubator Systems for premature babies and newborns. In the Cardio business area we concentrate on the development of products for the detection of atrial fibrillation as a measure to prevent strokes. The Respiratory segment develops and markets products for the assessment of pulmonary function. In all mainly business areas, Geratherm has patent-protected basic technologies at its disposal. We regard ourselves as a research-based medical products company with a clear focus on medical diagnostic devices that generate vital data. Geratherm shares have been listed in the Prime Standard segment of the Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues to be represented in the German Entrepreneurial Index and in the German Healthcare Index.